TrialThe Journal of infectious diseases2017

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.

Li-Min Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.